<DOC>
	<DOCNO>NCT01810783</DOCNO>
	<brief_summary>To determine safety efficacy brexpiprazole long-term treatment .</brief_summary>
	<brief_title>Brexpiprazole Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Brexpiprazole</mesh_term>
	<criteria>The patient complete leadin study 14644A . The patient judge potentially benefit 52week treatment brexpiprazole accord clinical opinion investigator . The patient agree protocoldefined use effective contraception . The patient diagnose primary psychiatric disorder schizophrenia Study 14644A . The patient clinically significant unstable illness diagnose Study 14644A . The patient , opinion investigator accord ColumbiaSuicide Severity Rating Scale ( CSSRS ) , significant risk suicide . The patient abnormal ECG abnormal ECG test , investigator 's opinion , clinically significant . The patient , investigator 's opinion , unlikely comply protocol unsuitable reason . Other inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>